Sensivion Alternatives: Neuvelys, Simpler Supplements and Evidence-Based Options
Neuvelys is the closest branded Sensivion alternative identified because the supplied labels appear to list the same principal ingredients and amounts. If that match remains current, switching between them changes the branding, marketing and possibly the seller or checkout — not the core labelled formula.
That makes Neuvelys a close commercial alternative, but not necessarily a meaningfully different formula. JeffsReviews has not confirmed that the two products share a manufacturer, raw materials or production process.
A simpler single-ingredient supplement reduces formula complexity, but it is not automatically more effective and is not an established tinnitus treatment.
For visitors seeking an evidence-aligned alternative to buying another supplement, audiological assessment, hearing support when hearing loss is present and tinnitus-related CBT for ongoing distress may be more relevant routes.
Jeff has not personally used or directly compared Sensivion and Neuvelys.
This is a comparative editorial analysis. It is not personal medical advice, a diagnosis, a treatment plan, a claim that one route is suitable for every person, or proof that any supplement treats tinnitus.


Sensivion alternatives at a glance
- Closest branded comparison:
- Neuvelys
- Current classification:
- Potentially the same principal labelled formula, subject to a current label recheck
- Meaningfully different formula?:
- Not established from the supplied labels
- Simpler route:
- A single-ingredient product with a clearly disclosed amount and form
- Does simpler mean proven for tinnitus?:
- No
- Strongest guideline alignment:
- Assessment and management based on hearing status and impact
- Hearing support:
- Relevant only when hearing loss is present and appropriately assessed
- Tinnitus-related CBT:
- A management option for distress and day-to-day impact
- Sound support:
- Possible option; evidence and guideline recommendations are less certain
- Lowest product commitment:
- Do not purchase another supplement
- Finished-product proof for Sensivion:
- Not established
- Finished-product proof for Neuvelys:
- Not established from the evidence located
- Tested by Jeff:
- No
Main conclusion: the most useful alternative depends on what the visitor wants to change — branding, formula complexity, evidence standard or the decision to buy a supplement at all.
What makes an alternative meaningfully different?
The comparison considers principal formula, ingredient amounts and forms, excipients, serving instructions, bottle size, current official positioning, finished-product evidence, formula complexity, safety and interaction complexity, seller and checkout, total purchase commitment, whether a product purchase is required, guideline relevance and the main buyer objective.
A different bottle design or brand name does not automatically create a meaningfully different formula. Non-supplement routes are included because some visitors are not looking for another bottle — they are looking for a better-supported way to assess or manage the problem.
What is being replaced when someone looks for a Sensivion alternative?
According to the supplied Sensivion label: 30 capsules per bottle, one capsule daily for adults, magnesium 80 mg (21% NRV), alpha-lipoic acid 100 mg, butcher's-broom root extract 50 mg, L-carnitine 10 mg, turmeric rhizome extract 10 mg standardised to 95% curcuminoids, and coenzyme Q10 5 mg as ubiquinone.
At the time of the current source check, the official Sensivion page used restrained wording around magnesium, normal functioning of the nervous system, simple daily use and food-supplement status.
The Sensivion alternative question is therefore not only "Which product has similar ingredients?" It is also "Does the buyer want the same formula, fewer ingredients or a completely different approach?"
Neuvelys is the closest comparison — but may not change the formula
Comparing the supplied Sensivion and Neuvelys labels, the principal ingredients and amounts appear to overlap. Where the current labels match, the honest editorial description is: the supplied Sensivion and Neuvelys labels list the same principal ingredients and amounts.
That does not prove that the finished products are chemically identical, made by the same manufacturer or produced under identical conditions. It does not establish shared raw materials, identical excipients, identical bioavailability, identical sellers or identical return conditions.
JeffsReviews therefore uses "label-equivalent principal formula" only when the current line-by-line comparison supports it, and avoids terms such as "exact same product", "identical product", "rebrand", "white-label duplicate", "copy" or "clone" unless reliable corporate or manufacturing evidence establishes them.
Sensivion and Neuvelys label comparison
A current label recheck is required before publication. Neuvelys values are represented as "use verified current label" so that any change on the Neuvelys side triggers an explicit re-check rather than a silent assumption of overlap.
| Label element | Sensivion | Neuvelys | Match status | Why it matters |
|---|---|---|---|---|
| Capsule count | 30 capsules | Use verified current label | Current recheck required | Determines how many days one bottle covers. |
| Suggested use | One capsule daily for adults | Use verified current label | Current recheck required | Doubling the serving doubles ingredient exposure and cost. |
| Magnesium | 80 mg, 21% NRV | Use verified current label | Current recheck required | Sets total daily magnesium intake and NRV contribution. |
| Alpha-lipoic acid | 100 mg (form not specified) | Use verified current label | Current recheck required | Form and isomer influence stability and comparability with research. |
| Butcher's broom | 50 mg Ruscus aculeatus root extract | Use verified current label | Current recheck required | Preparation and extract ratio determine what the amount represents. |
| L-carnitine | 10 mg | Use verified current label | Current recheck required | Form (L-carnitine vs acetyl-L-carnitine) affects comparability with tinnitus case-study evidence. |
| Turmeric | 10 mg rhizome extract, 95% curcuminoids | Use verified current label | Current recheck required | Standardisation and absorption format materially change intake. |
| Coenzyme Q10 | 5 mg as ubiquinone | Use verified current label | Current recheck required | Form (ubiquinone vs ubiquinol) and amount define comparability with pilot research. |
| Capsule shell | Hypromellose (vegetable) | Use verified current label | Current recheck required | Affects suitability for people avoiding gelatine. |
| Excipients | Microcrystalline cellulose, magnesium salts of edible fatty acids, silicon dioxide | Use verified current label | Current recheck required | Complete excipient overlap is required to describe formulas as label-equivalent. |
| Warnings | Standard adult food-supplement warnings; not for under-18s, pregnant or nursing mothers | Use verified current label | Current recheck required | Warning parity matters when comparing safety. |
| Distributor | Digistore24 MSLW Limited, Dublin, Ireland | Use verified current label | Current recheck required | Distributor identity is separate from manufacturing identity. |
| Net weight | 17 g | Use verified current label | Current recheck required | Sanity check for capsule count and fill. |
Capsule count
Sensivion: 30 capsules
Neuvelys: Use verified current label
Current recheck required
Determines how many days one bottle covers.
Suggested use
Sensivion: One capsule daily for adults
Neuvelys: Use verified current label
Current recheck required
Doubling the serving doubles ingredient exposure and cost.
Magnesium
Sensivion: 80 mg, 21% NRV
Neuvelys: Use verified current label
Current recheck required
Sets total daily magnesium intake and NRV contribution.
Alpha-lipoic acid
Sensivion: 100 mg (form not specified)
Neuvelys: Use verified current label
Current recheck required
Form and isomer influence stability and comparability with research.
Butcher's broom
Sensivion: 50 mg Ruscus aculeatus root extract
Neuvelys: Use verified current label
Current recheck required
Preparation and extract ratio determine what the amount represents.
L-carnitine
Sensivion: 10 mg
Neuvelys: Use verified current label
Current recheck required
Form (L-carnitine vs acetyl-L-carnitine) affects comparability with tinnitus case-study evidence.
Turmeric
Sensivion: 10 mg rhizome extract, 95% curcuminoids
Neuvelys: Use verified current label
Current recheck required
Standardisation and absorption format materially change intake.
Coenzyme Q10
Sensivion: 5 mg as ubiquinone
Neuvelys: Use verified current label
Current recheck required
Form (ubiquinone vs ubiquinol) and amount define comparability with pilot research.
Capsule shell
Sensivion: Hypromellose (vegetable)
Neuvelys: Use verified current label
Current recheck required
Affects suitability for people avoiding gelatine.
Excipients
Sensivion: Microcrystalline cellulose, magnesium salts of edible fatty acids, silicon dioxide
Neuvelys: Use verified current label
Current recheck required
Complete excipient overlap is required to describe formulas as label-equivalent.
Warnings
Sensivion: Standard adult food-supplement warnings; not for under-18s, pregnant or nursing mothers
Neuvelys: Use verified current label
Current recheck required
Warning parity matters when comparing safety.
Distributor
Sensivion: Digistore24 MSLW Limited, Dublin, Ireland
Neuvelys: Use verified current label
Current recheck required
Distributor identity is separate from manufacturing identity.
Net weight
Sensivion: 17 g
Neuvelys: Use verified current label
Current recheck required
Sanity check for capsule count and fill.
The current Neuvelys website must be checked against the physical label
During one current page check, the Neuvelys landing page displayed stronger tinnitus-relief marketing, references to ringing, calm, focus and hearing, and a "two capsules a day" statement. The previously supplied Neuvelys label displayed one capsule daily.
This is treated as a possible website-versus-label discrepancy that requires a fresh live check. Buyers should not silently pick one wording over the other, and daily ingredient intake should not be recalculated until the serving discrepancy is resolved.
The current Neuvelys website and supplied label do not present the same daily-use wording. Buyers should follow the physical label supplied with the product and seek clarification from the responsible seller when online directions conflict.
This page does not recommend taking two capsules, taking one capsule, doubling the labelled amount, or following a marketing page over a physical label. It flags the conflict and stops there.
The brands may use different marketing even when labels overlap
Sensivion
- Magnesium
- Normal nervous-system function
- Daily routine
- Clear product information
Neuvelys
- Tinnitus relief
- Ringing
- Calm
- Focus
- Hearing support
- Ear health
Different marketing language does not establish a different formula or a stronger clinical result. Stronger promotional wording does not become clinical evidence, and merchant claims are not editorial fact.
Does either formula have stronger finished-product evidence?
Sensivion
Clearly matching finished-product human trial: not located in the completed searches.
Neuvelys
Clearly matching finished-product human trial: not located from the evidence reviewed.
Ingredient studies are not finished-product trials, a matching label does not transfer a clinical trial, stronger marketing does not create stronger evidence, merchant testimonials are not clinical outcomes, a commercial guarantee is not efficacy evidence, a large package is not evidence, and an authorised magnesium claim is not proof of tinnitus improvement.
Neither product has a demonstrated finished-product advantage based on the evidence located.
Complete Sensivion effectiveness and clinical-evidence analysis · Complete Neuvelys effectiveness analysis
Compare total commitment — not only the per-bottle headline
Per-bottle headlines can look similar while total package commitment, shipping wording, VAT wording, seller, checkout provider, payment frequency and return conditions differ. The reliable comparison is total payment on the same checkout, on the same day, in the same currency.
Current total-cost comparison unavailable in this page's fixed content — check each dedicated buying guide for the most recent verified figures.
Current Sensivion package totals and checkout terms · Current Neuvelys package totals and checkout terms
A simpler formula can be easier to evaluate — but is not automatically more effective
Potential advantages
- Fewer active ingredients
- Easier label interpretation
- Easier form comparison
- Easier total-intake calculation
- Fewer simultaneous ingredient uncertainties
- Easier attribution if an unwanted effect occurs
- Potentially lower purchase commitment
Important limitations
- Simpler does not mean clinically proven
- Simpler does not mean safer for every person
- A single ingredient can still interact with medicines
- The relevant dose and form may be uncertain
- A nutrient may be unnecessary
- Ingredient studies may not apply to an individual
- Research doses should not be reproduced without professional advice
This page does not recommend a specific retail single-ingredient product and does not add unauthorised retailer links.
Magnesium alone removes five ingredients — but not the evidence gap
Sensivion contains 80 mg of magnesium per capsule. A magnesium-only product may offer one active ingredient, a clearer magnesium form, a clearer elemental amount and easier comparison with total dietary and supplemental intake.
Magnesium is not an established tinnitus treatment. Sensivion's authorised claim concerns normal nervous-system function, which does not establish symptom improvement. Existing tinnitus research used different amounts in weak study designs, different magnesium forms are not automatically interchangeable, more magnesium is not automatically better and additional intake may be inappropriate for some people.
A magnesium-only product is a formula-simplicity alternative, not a proven tinnitus alternative.
Alpha-lipoic acid alone offers clearer dosing — but no direct Sensivion replacement evidence
Sensivion contains 100 mg alpha-lipoic acid with an unspecified form. A standalone product may make it easier to evaluate exact amount, isomer or form, excipients and serving frequency.
Relevant studies used materially different amounts, study designs were limited, standalone research did not test Sensivion, a higher amount is not automatically appropriate, alpha-lipoic acid can have safety and interaction considerations, and it is not an established tinnitus treatment.
This is a transparency and simplicity alternative — not a demonstrated outcome replacement.
CoQ10 alone is simpler, but the tinnitus pilot does not establish a benefit
Sensivion contains 5 mg CoQ10 as ubiquinone. A standalone product may disclose the exact CoQ10 amount, whether it is ubiquinone or ubiquinol, any carrier or delivery system and the serving.
A small tinnitus pilot used approximately 300 mg daily, found no overall tinnitus-score effect, was nonrandomised, and its subgroup observation was exploratory. It did not test Sensivion and does not establish that standalone CoQ10 treats tinnitus.
A CoQ10-only product changes formula complexity, but current evidence does not make it a proven tinnitus solution.
Audiological assessment moves from product selection to diagnosis
An audiological assessment is an evidence-aligned starting point when hearing status is unclear or symptoms are new or concerning. It does not promise a cure or a specific cause, and it is not a supplement purchase. NICE NG155 (2020) and the AAO-HNS 2014 clinical practice guideline both frame appropriate assessment as the basis for the management route.
Hearing support belongs to a specific group — not everyone with tinnitus
Where hearing loss is present and appropriately assessed, hearing support is a guideline-supported route. It is not an appropriate route for tinnitus without confirmed hearing loss. This page therefore does not recommend hearing devices to someone without hearing loss.
Tinnitus-related CBT addresses distress and impact
Tinnitus-related cognitive behavioural therapy is a guideline-supported management option for appropriate adults. It targets the distress and day-to-day impact of tinnitus rather than promising removal of the sound or a cure.
Sound and environmental support: possible, not guaranteed
Sound and environmental strategies are sometimes helpful, but guideline recommendations and evidence quality differ between AAO-HNS and NICE. This page presents sound support as a possibly useful low-commitment option, not a guaranteed route.
Choosing no new supplement is a legitimate alternative
When the evidence, formula complexity, checkout or package commitment does not meet the buyer's threshold, doing nothing about supplement purchasing is a valid alternative. It should not be used to delay appropriate assessment of new or concerning symptoms.
The best alternative depends on what you want to change
Closest branded comparison
Neuvelys
Only after confirming the current label; may be a branding alternative rather than a new formula.
Fewer ingredients
A clearly labelled single-ingredient category
Simpler does not mean proven or suitable.
Strongest evidence standard
Assessment and guideline-aligned management
The appropriate route depends on hearing status and tinnitus impact.
Hearing loss is present
Professional hearing-device evaluation
Not for tinnitus without hearing loss.
Distress is the main problem
Tinnitus-related CBT or appropriately delivered psychological support
Aims to reduce impact rather than promise elimination of the sound.
Lowest purchase commitment
No new supplement or low-cost environmental sound support
Must not delay appropriate assessment.
Wants the original six-ingredient formula
Sensivion remains the baseline option
Only with realistic expectations and after reviewing the label, warnings, seller and total price.
Full comparison matrix
| Option | What changes | Direct evidence | Purchase | Main advantage | Main limitation | Suits |
|---|---|---|---|---|---|---|
| Sensivion | Baseline six-ingredient food supplement | No clearly matching finished-product trial located | Bottle purchase | Discloses a complete ingredient list at declared amounts | No finished-product effectiveness proof | Buyer wants the original disclosed formula |
| Neuvelys | Different brand; principal labelled formula may overlap | No clearly matching finished-product trial located from the evidence reviewed | Bottle purchase | Closest label-level comparison to Sensivion | May change branding without changing the core formula; current website-versus-label wording may differ | Buyer wants the closest branded comparison |
| Simpler single-ingredient supplement | One active ingredient at a clearly disclosed amount | Ingredient studies exist; not a Sensivion replacement trial | Bottle purchase | Easier to evaluate amount, form and interactions | Simpler does not mean proven or automatically suitable | Buyer prioritises formula simplicity |
| Audiological assessment | Moves from product selection to hearing-status assessment | Guideline-aligned assessment route | Not a supplement purchase | Can inform relevant management | Does not promise a cure or specific cause | Buyer prioritises assessment |
| Hearing support (with hearing loss) | Addresses hearing function where loss is present | Guideline-supported in the appropriate group | May involve a device or service | Relevant to assessed hearing loss | Not appropriate for tinnitus without hearing loss | Buyer has confirmed hearing loss |
| Tinnitus-related CBT | Targets distress and daily impact | Guideline-supported for appropriate adults | May involve a service | Addresses the impact of tinnitus | Does not promise removal of the sound | Buyer's main difficulty is ongoing distress |
| Sound and environmental support | Changes the sound environment | Mixed and approach-dependent | Not necessarily | Can be low commitment | Guideline uncertainty and variable response | Buyer wants a practical environmental strategy |
| No new supplement | Avoids another product purchase | Not an intervention claim | No | No additional formula or package commitment | Does not replace assessment when needed | Evidence threshold or purchase confidence not met |
Sensivion
What changes: Baseline six-ingredient food supplement
Direct evidence: No clearly matching finished-product trial located
Purchase: Bottle purchase
Main advantage: Discloses a complete ingredient list at declared amounts
Main limitation: No finished-product effectiveness proof
Suits: Buyer wants the original disclosed formula
Neuvelys
What changes: Different brand; principal labelled formula may overlap
Direct evidence: No clearly matching finished-product trial located from the evidence reviewed
Purchase: Bottle purchase
Main advantage: Closest label-level comparison to Sensivion
Main limitation: May change branding without changing the core formula; current website-versus-label wording may differ
Suits: Buyer wants the closest branded comparison
Simpler single-ingredient supplement
What changes: One active ingredient at a clearly disclosed amount
Direct evidence: Ingredient studies exist; not a Sensivion replacement trial
Purchase: Bottle purchase
Main advantage: Easier to evaluate amount, form and interactions
Main limitation: Simpler does not mean proven or automatically suitable
Suits: Buyer prioritises formula simplicity
Audiological assessment
What changes: Moves from product selection to hearing-status assessment
Direct evidence: Guideline-aligned assessment route
Purchase: Not a supplement purchase
Main advantage: Can inform relevant management
Main limitation: Does not promise a cure or specific cause
Suits: Buyer prioritises assessment
Hearing support (with hearing loss)
What changes: Addresses hearing function where loss is present
Direct evidence: Guideline-supported in the appropriate group
Purchase: May involve a device or service
Main advantage: Relevant to assessed hearing loss
Main limitation: Not appropriate for tinnitus without hearing loss
Suits: Buyer has confirmed hearing loss
Tinnitus-related CBT
What changes: Targets distress and daily impact
Direct evidence: Guideline-supported for appropriate adults
Purchase: May involve a service
Main advantage: Addresses the impact of tinnitus
Main limitation: Does not promise removal of the sound
Suits: Buyer's main difficulty is ongoing distress
Sound and environmental support
What changes: Changes the sound environment
Direct evidence: Mixed and approach-dependent
Purchase: Not necessarily
Main advantage: Can be low commitment
Main limitation: Guideline uncertainty and variable response
Suits: Buyer wants a practical environmental strategy
No new supplement
What changes: Avoids another product purchase
Direct evidence: Not an intervention claim
Purchase: No
Main advantage: No additional formula or package commitment
Main limitation: Does not replace assessment when needed
Suits: Evidence threshold or purchase confidence not met
Changing products does not automatically remove safety concerns
- Neuvelys may retain the same ingredient-level concerns when its label matches Sensivion.
- Switching brands does not remove an ingredient interaction.
- A single ingredient may still have meaningful precautions.
- Combining Sensivion with another supplement can duplicate ingredients.
- More capsules can increase exposure.
- A marketing-page serving should not override the product label.
- Visitors should not combine products to reproduce research amounts.
- Product-specific warnings must be checked.
Complete Sensivion side-effects and interaction guide · Complete Neuvelys safety guide
Questions to answer before choosing an alternative
- Do I want a different brand or a different formula?
- Does the current label actually differ?
- Are the principal ingredient amounts different?
- Does the website serving match the physical label?
- Is the ingredient form disclosed?
- Am I looking for clinical evidence or only formula similarity?
- Is the product supported by a finished-product trial?
- Is the total package payment clear?
- Is the seller identified?
- Is the payment one-time or recurring?
- Are shipping and return conditions clear?
- Does the alternative duplicate ingredients I am already taking?
- Have the warnings and interactions been reviewed?
- Is hearing loss present?
- Is distress the main issue?
- Would an assessment be more useful than another supplement?
- Am I relying on a testimonial rather than evidence?
- Would choosing no new product better match my evidence threshold?
A useful alternative should change the factor that matters — not merely the brand name.
Sensivion alternatives: strengths and limitations
Strengths of this comparison
- Uses genuine supplied product labels
- Compares principal ingredient amounts
- Separates branding from formula differences
- Includes non-commercial alternatives
- Does not assume a supplement is the correct answer
- Distinguishes clinical evidence from marketing
- Accounts for formula complexity
- Includes purchase commitment
- Includes safety and interaction considerations
- Uses recognised tinnitus guidance
- Provides objective-based choices
- Discloses Jeff's lack of personal testing
Important limitations
- Labels and websites can change
- The Neuvelys website and supplied label may conflict
- Matching labels do not prove identical manufacturing
- Seller and checkout entities may differ
- Current prices are volatile
- No personal-use comparison was performed
- No laboratory testing was performed
- No alternative is universally suitable
- No single ingredient is an established tinnitus treatment
- Hearing support depends on hearing loss
- CBT addresses distress rather than proving sound elimination
- Sound-support evidence is uncertain
- Public guidance cannot determine an individual's needs
Sensivion alternatives verdict: Neuvelys is the closest label match, but the most meaningful alternative may not be another supplement
Neuvelys is the closest branded Sensivion alternative located. The supplied labels appear to list the same principal ingredients and amounts, so it may change the branding, marketing, seller or checkout without providing a meaningfully different core formula.
That label overlap does not prove the finished products are identical, share a manufacturer or produce the same effects. The current Neuvelys website must also be reconciled with its supplied label because the online daily-use wording may differ.
A single-ingredient supplement can reduce formula complexity and make the amount and form easier to evaluate. It does not, however, become an established tinnitus treatment simply because it contains fewer ingredients.
For someone whose priority is the strongest evidence-aligned route, audiological assessment, hearing support where hearing loss is present, and tinnitus-related CBT where distress continues are more meaningfully different from Sensivion than switching between two similar supplement labels.
Sound or environmental support may be a low-commitment option, although guidelines differ and the evidence does not support a guaranteed result.
Choosing not to purchase another supplement is also reasonable when the evidence, formula complexity, checkout or package commitment does not meet the buyer's threshold. That decision should not be used to delay appropriate assessment of new or concerning symptoms.
No single alternative is best for everyone. Neuvelys is the closest commercial comparison; a single-ingredient product is the simpler formula route; assessment and appropriately selected management are the stronger evidence-oriented route.
Sensivion remains relevant only for buyers who specifically want its six-ingredient formula, understand the evidence limitations and verify the current label, warnings, seller and complete package cost.
Jeff has not used or directly compared Sensivion and Neuvelys.
If Sensivion still best matches your preferred formula, use the current merchant page to verify the label, serving, seller, complete package total and guarantee terms before deciding.
Check the current Sensivion label and offerOur Sensivion research
Decision
Formula and Use
Buying
Frequently asked questions
Sources
Sensivion label and official information
- [1] Sensivion. "Genuine supplied Sensivion English label." Sensivion, 2026. Sensivion formula, amounts, serving, excipients, warnings and distributor. View source
- [2] Sensivion. "Current official Sensivion English page." Sensivion, 2026. Current public positioning and daily-use wording; not used as independent effectiveness evidence. View source
Neuvelys label and official information
- [3] Neuvelys. "Genuine supplied Neuvelys English label." Neuvelys, 2026. Neuvelys formula, amounts, serving, excipients, warnings and distributor. View source
- [4] Neuvelys. "Current official Neuvelys English page." Neuvelys, 2026. Current public positioning, daily-use wording and merchant outcome claims; not used as independent effectiveness evidence. View source
Current systematic-review evidence
- [5] Menon R, Ziner J, Tolordava A, et al.. "Effectiveness of Over-The-Counter Treatments for Tinnitus Symptom Relief: A Systematic Review." Laryngoscope Investigative Otolaryngology, 2026. OTC tinnitus evidence heterogeneity and absence of firm conclusions. View source
NICE tinnitus guidance
- [6] National Institute for Health and Care Excellence. "Tinnitus: assessment and management (NG155)." NICE, 11 March 2020. Audiological assessment, hearing-device recommendations where hearing loss is present, stepped psychological support, CBT and sound-therapy uncertainty. View source
AAO-HNS tinnitus guidance
- [7] American Academy of Otolaryngology–Head and Neck Surgery Foundation. "Clinical Practice Guideline: Tinnitus." AAO-HNSF, 2014. Hearing-aid evaluation with hearing loss, CBT recommendation, sound therapy as an option, and dietary supplements not recommended for persistent, bothersome tinnitus. View source
Regulatory health-claim context
- [8] European Commission. "Nutrition and Health Claims." European Commission. Authorised nutrient-function wording context. View source
- [9] European Commission. "EU Register of Health Claims." European Commission. Authorised magnesium wording; difference between nutrient-function claims and finished-product proof. View source